DiscoverThe BellcastMeet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2
Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Update: 2023-02-22
Share

Description

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
- (0:34 ) Impacts of Ferring's FDA approval on Microba
- (5:30 ) Drivers behind Microba's increase in revenue
- (7:12 ) What 2023 looks like for Monash IVF
- (8:39 ) Monash IVF's rating
- (11:45 ) Monash IVF's impact from legal action

Note: This interview was filmed on 7 February 2023.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Bell Direct